Short-Chain Fatty Acid Propionate Alleviates Akt2 Knockout-Induced Myocardial Contractile Dysfunction

Figure 1

Oral glucose tolerance test (OGTT, 2 g/kg body weight) in WT and Akt2 knockout (AKTKO) mice treated with or without propionate (0.3 g/kg, p.o.) for 7 days. (a) OGTT curve; (b) Area underneath the curve plotted in panel A. Mean ± SEM, 𝑛=7-8 mice per group, and *𝑃<0.05 versus WT group.

(a)

(b)